1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MIRUM PHARMACEUTICALS INC
Mirum Pharmaceuticals Inc XNAS: MIRM

Mirum Pharma Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestat...

Read More
90.93 2.15 (2.42%)
146.56% Gain from 52W Low
768.7K
XNAS Volume

XNAS 10 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Mirum Pharma Inc is scheduled for today, for the purpose of 2026 Leerink Partners Global Healthcare Conference See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
10.0 / 100
Momentum Score
Technically Neutral
51.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
125
1Yr Price target upside is 37%
11 analysts

16

S

7

W

5

O

1

T

SWOT Analysis

Mirum Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..